Insider · CIK 0001813701

Burak Eric

Reports to the SEC for 1 company · HAMILTON, A6

sec.gov

Transactions

Companies

Filings

CIK

0001813701

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-04	Fusion Pharmaceuticals Inc.D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−38.5K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−160K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−81.1K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−72.3K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−38.6K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−44.8K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−69.9K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−139K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−41K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−45.5K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−45.5K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−168K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−250K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−106K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−63.7K sh	—	—	0
2024-01-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+106K sh	—	—	106,100
2024-01-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsA Award	Chief Technology Officer	AAward	+63.7K sh	—	—	63,700
2023-01-05	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+250K sh	—	—	250,000
2022-02-01	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+168K sh	—	—	168,200
2021-02-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+139K sh	—	—	139,000
2021-02-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+41K sh	—	—	41,000
2021-02-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+137K sh	—	—	136,600
2020-06-25	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+44.8K sh	—	—	44,754
2020-06-25	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+70K sh	—	—	69,980
2020-02-06	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+38.6K sh	—	—	38,561

Recent filings

Accepted (ET)
Jun 44
Burak Eric0000950170-24-068881
SEC(opens sec.gov)
Jan 54
Burak Eric0000950170-24-002297
SEC(opens sec.gov)
Jan 94
Burak Eric0001209191-23-002495
SEC(opens sec.gov)
Feb 34
Burak Eric0001209191-22-007046
SEC(opens sec.gov)
Feb 84
Burak Eric0000899243-21-005321
SEC(opens sec.gov)

Companies

Fusion Pharmaceuticals Inc.Chief Technology Officer

Address

C/O FUSION PHARMACEUTICALS INC. 270 LONGWOOD ROAD SOUTH

HAMILTON, A6, L8P 0A6